Liu et al. Cancer Cell Int (2016) 16:40 DOI 10.1186/s12935-016-0316-3
Cancer Cell International
RETRACTION NOTE
Open Access
Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans Guijuan Liu1, Qiang Wu2, Guilan Liu3, Xueying Song4 and Jihong Zhang2*
Retraction to: Cancer Cell International (2015) 15:18 DOI 10.1186/s12935‑014‑0154‑0 The editors are retracting this article [1] as it has been previously published in the International Journal of Clinical and Experimental Pathology [2] and it is therefore a redundant publication. The authors could not be reached by the journal for comment on the retraction. Author details 1 Department of Cytology Laboratory, People’s Hospital of Linyi, Linyi 276300, Shandong, China. 2 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China. 3 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China. 4 Department of Thoracic Surgery, the People’s Hospital of Rizhao, Rizhao, China. The online version of the original article can be found under doi:10.1186/s12935-014-0154-0.
Received: 20 May 2016 Accepted: 20 May 2016
References 1. Liu G, Wu Q, Liu G, Song X, Zhang J. Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans. Cancer Cell Int. 2015;15:18. 2. Liu G, Wu Q, Liu G, Song X, Zhang J. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo. Int J Clin Exp Pathol. 2014;7(11):8279–89.
*Correspondence: [email protected] 2 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China Full list of author information is available at the end of the article
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Cancer Cell International
RETRACTION NOTE
Open Access
Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans Guijuan Liu1, Qiang Wu2, Guilan Liu3, Xueying Song4 and Jihong Zhang2*
Retraction to: Cancer Cell International (2015) 15:18 DOI 10.1186/s12935‑014‑0154‑0 The editors are retracting this article [1] as it has been previously published in the International Journal of Clinical and Experimental Pathology [2] and it is therefore a redundant publication. The authors could not be reached by the journal for comment on the retraction. Author details 1 Department of Cytology Laboratory, People’s Hospital of Linyi, Linyi 276300, Shandong, China. 2 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China. 3 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China. 4 Department of Thoracic Surgery, the People’s Hospital of Rizhao, Rizhao, China. The online version of the original article can be found under doi:10.1186/s12935-014-0154-0.
Received: 20 May 2016 Accepted: 20 May 2016
References 1. Liu G, Wu Q, Liu G, Song X, Zhang J. Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans. Cancer Cell Int. 2015;15:18. 2. Liu G, Wu Q, Liu G, Song X, Zhang J. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo. Int J Clin Exp Pathol. 2014;7(11):8279–89.
*Correspondence: [email protected] 2 Department of Nursing, People’s Hospital of Yinan, Linyi 276300, Shandong, China Full list of author information is available at the end of the article
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
